This biphasic dose-response demonstrates that "more is not better" there is an optimal concentration window for copper peptide efficacy
DOI:10.1002/cncr.28654 [ Links ] 36
The DOE Phase 0 SBIR/STTR assistance program is not part of this FY24 SBIR/STTR Phase I, Release 2 FOA and has a different application process, while applying for TABA is part of the FOA application
reports research grant support , on behalf of their institution, from Novo Nordisk and advisory/consultancy fees from Boehringer Ingelheim, Eli Lilly & Company, Gila Therapeutics Inc, GLW-01, International Medical Press, Novo Nordisk , Pfizer and ViiV
In that study, escitalopram and paroxetine produced a concentration-dependent increase in spontaneous contractions in isolated fallopian tubes
Huang PJ, Huang YC, Su MF, Yang TY, Huang JR, Jiang CP